Search results for: 'signaling pathways pi3k akt mtor signaling pi3k zstk474'
-
BA6139 Q134RSummary: Q134R, a neuroprotective hydroxyquinoline derivative, inhibits nuclear factors that activate T cell signaling. - BA7801 TAT-cyclo-CLLFVYSummary: TAT-cyclo-CLLFVY is a heterodimerized cyclic peptide inhibitor that inhibits hypoxic signaling in cancer cells.
-
A8764 Rapalink-1Target: mTORSummary: third-generation mTOR inhibitor -
B7337 Compound 401Summary: DNA-PK and mTOR inhibitor - BA1375 IlimaquinoneSummary: Ilimaquinone is a marine sponge-like metabolite that exerts antitumor activity through a GADD153-mediated signaling pathway.
- BA8535 LY900009Summary: LY900009 is a potent, orally active, signaling inhibitor that acts by selectively inhibiting gamma-secretase proteins.
- BA9119 TDI-011536Summary: TDI-011536 is a potent kinase inhibitor that interrupts signaling and may initiate proliferation of damaged cardiomyocytes.
-
A4097 CUDC-907Target: Histone Deacetylases (HDACs)|PI3KSummary: Potent PI3K/HDAC inhibitor -
B6171 CC-223Summary: mTOR inhibitor, orally bioavailable -
B5853 MHY14852 CitationTarget: mTORSummary: mTOR activator, autophage inhibitor